Some further information on the commercialization potential after phase 2 would be good. Could phase 3 be fully funded, if results are good? Don't think that this is widely appreciated!
Ann: Kidney Disease Drug Candidate Progressing to Human Trials, page-14
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.3¢ | 16.5¢ | $156.0K | 921.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 472066 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 184410 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |